| Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases |
123 |
| Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis |
25 |
| Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease |
25 |
| Regulation and function of endothelial glycocalyx layer in vascular diseases |
23 |
| Role of flow-sensitive microRNAs and long noncoding RNAs in vascular dysfunction and atherosclerosis |
20 |
| LncRNAs in vascular biology and disease |
20 |
| The first 3500 years of aspirin history from its roots - A concise summary |
19 |
| Uric acid: from a biological advantage to a potential danger. A focus on cardiovascular effects |
16 |
| Angiotensin II and vascular damage in hypertension: Role of oxidative stress and sympathetic activation |
15 |
| The morphological and molecular mechanisms of epithelial/endothelial-to-mesenchymal transition and its involvement in atherosclerosis |
13 |
| The function of miR- miR-145 and the MiR-143 host gene in cardiovascular development and disease |
13 |
| A positive feedback loop between IL-1 beta, LPS and NEU1 may promote atherosclerosis by enhancing a pro-inflammatory state in monocytes and macrophages |
13 |
| Hyperglycaemic impairment of PAR2-mediated vasodilation: Prevention by inhibition of aortic endothelial sodium-glucose-co-Transporter-2 and minimizing oxidative stress |
13 |
| Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis |
13 |
| Long non-coding RNAs in vascular biology and disease |
12 |
| Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis |
12 |
| Chebulagic acid Chebulinic acid and Gallic acid, the active principles of Triphala, inhibit TNF alpha induced pro-angiogenic and pro-inflammatory activities in retinal capillary endothelial cells by inhibiting p ERK and NFkB phosphorylation |
11 |
| Nrf2 in aging - Focus on the cardiovascular system |
11 |
| Elucidating the contributory role of microRNA to cardiovascular diseases (a review) |
11 |
| The function of long non-coding RNAs in vascular biology and disease |
11 |
| Non-coding RNAs in vascular remodeling and restenosis |
10 |
| Inorganic nitrite and nitrate in cardiovascular therapy: A better alternative to organic nitrates as nitric oxide donors? |
10 |
| Estrogen in vascular smooth muscle cells: A friend or a foe? |
9 |
| Nitric oxide and the biology of pregnancy |
9 |
| Non-coding RNAs in lipid metabolism |
8 |
| Cellular traffic through afferent lymphatic vessels |
8 |
| Chemerin in human cardiovascular disease |
8 |
| Inhibition of miR-29b suppresses MAPK signaling pathway through targeting SPRY1 in atherosclerosis |
8 |
| Vasculature on the clock: Circadian rhythm and vascular dysfunction |
8 |
| MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension |
8 |
| Amorphous nano-selenium quantum dots improve endothelial dysfunction I it in rats and prevent atherosclerosis in mice through Na+ /H+ exchanger 1 inhibition |
7 |
| Long non-coding RNA-SRA promotes neointimal hyperplasia and vascular smooth muscle cells proliferation via MEK-ERK-CREB pathway |
7 |
| Colchicine reduces platelet aggregation by modulating cytoskeleton rearrangement via inhibition of cofilin and LIM domain kinase 1 |
7 |
| Cinnamaldehyde protects VSMCs against ox-LDL-induced proliferation and migration through S arrest and inhibition of p JNK/MAPKs and NF-kappa B |
7 |
| HMGB1/TLR4 promotes hypoxic pulmonary hypertension via suppressing BMPR2 signaling |
7 |
| Rat inferior caval vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157 |
7 |
| Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling |
7 |
| Effects of endurance training on serum lipids |
7 |
| Lactadherin: An unappreciated haemostasis regulator and potential therapeutic agent |
6 |
| Resveratrol attenuates hyperproliferation of vasculat smooth muscle cells from spontaneously hypertensive rats: Role of ROS and ROS-mediated cell signaling |
6 |
| FNDC5 inhibits foam cell formation and monocyte adhesion in vascular smooth muscle cells via suppressing NF kappa B-mediated NLRP3 upregulation |
6 |
| Diabetic macroangiopathy: Pathogenetic insights and novel therapeutic approaches with focus on high glucose-mediated vascular damage |
6 |
| Innate and adaptive immunity in atherosclerosis |
6 |
| Linking diabetic vascular complications with LncRNAs |
6 |
| Pharmacological strategies to inhibit intra-plaque angiogenesis in atherosclerosis |
6 |
| Beyond endothelial cells: Vascular endothelial growth factors in heart, vascular anomalies and placenta |
6 |
| Chronic administration of sodium nitrite prevents hypertension and protects arterial endothelial function by reducing oxidative stress in angiotensin II-infused mice |
6 |
| Serum adiponectin levels predict acute coronary syndrome (ACS) in patients with severe carotid stenosis |
6 |
| Thyroid hormones affect nitrergic innervation function in rat mesenteric artery: Role of the PI3K/AKT pathway |
6 |
| Effects of psychopharmacological treatment with antipsychotic drugs on the vascular system |
6 |
